Nanoco Group Plc · LSE:NANO

Nanoco — 19th Annual Needham Growth Conference 2017

32 slides from Nanoco's conference presentation, January 2017

  1. Slide 1: Investor Presentation

    INVESTOR PRESENTATION 19th Annual Needham Growth Conference January 2017

  2. Slide 2: Disclaimer

    DISCLAIMER 1 The following presentation is being made only to, and is only directed at, persons to whom such presentation may lawfully be communicated (“relevant persons”). Any person who is not a relevant person should not act or rely on this presentation or any of its contents. This presentation d

  3. Slide 3: Investment Highlights

    INVESTMENT HIGHLIGHTS 2 • A pioneer in the development and production of CFQD® cadmium- free quantum dots • Scalable "platform technology" with multiple markets and product applications • Cost and performance competitive versus OLED technology • Key target markets are display, lighting, bio-imaging

  4. Slide 4: What is a Quantum Dot?

    OVERVIEW 3 WHAT IS A QUANTUM DOT? • Tiny particles of a fluorescent semiconductor material • 1 to 10 nanometers in diameter • Size of the quantum dot determines the spectrum of light emitted • Smaller = blue; larger = red • Quantum dots can also be tuned to light beyond visible light into the Infra-

  5. Slide 5: Nanoco Advantages

    OVERVIEW 4 NANOCO ADVANTAGES • World leader in heavy metal free quantum dots • Unique “seeding process” enables mass production • Bright and energy efficient • Highly tunable to emit a specific color on the spectrum • Quantum dot surface can be chemically modified for different end use applications,

  6. Slide 6: Value Creation

    OVERVIEW 5 VALUE CREATION 1) CFQD® quantum dots 2) CFQD® quantum 3) CFQD® quantum 4) CFQD® quantum dots dots + Resin dots/Resin in device product CORE BUSINESS CORE BUSINESS Developing & Ensuring Nanoco’s CFQD® quantum dots Nanoco’s near term manufacturing CFQD® quantum dots are incorporated into fi

  7. Slide 7: Key Markets Are Large

    OVERVIEW 6 KEY MARKETS ARE LARGE High CRI LED Biological imaging Application LCD backlighting Thin film solar lighting In-vivo & in-vitro diagnostic Water soluble CFQD® CFQD® quantum CFQD® quantum dots quantum dots Technology dots CFQD® CIGS nanomaterials film Functionalized CFQD® quantum dots resin

  8. Slide 8: Benefits of CFQD Quantum Dot Film

    DISPLAY 7 BENEFITS OF CFQD® QUANTUM DOT FILM

  9. Slide 9: QD Market Forecast by Application and Screen Size

    DISPLAY 8 QD MARKET FORECAST BY APPLICATION AND SCREEN SIZE Source: IHS

  10. Slide 10: QD Market Forecast by Usage Type and Composition

    DISPLAY 9 QD MARKET FORECAST BY USAGE TYPE AND COMPOSITION Source: IHS

  11. Slide 11: CES 2017

    DISPLAY 10 CES 2017 • TCL, Hisense and TPV-Philips exhibited large screen, ultra high definition, wide color gamut prototype LCD TVs at Nanoco’s suite at Samsung has trail blazed the way, previously with CES 2017 its SUHD TV range, and now with its QLED TV and • All three use CFQD® Fine Color Film™,

  12. Slide 12: Key Partnerships

    DISPLAY 11 KEY PARTNERSHIPS DOW CHEMICAL • Announced January 2013; modified March 2016 • Changed from exclusive to non-exclusive in March 2016 • Non-exclusive worldwide technology licensing agreement with royalty payments WAH HONG • Announced July 2016 • 7 year non-exclusive material supply and lice

  13. Slide 13: Components of the Dow Agreement

    DISPLAY 12 COMPONENTS OF THE DOW AGREEMENT • The Dow Chemical Company has a major international electronic materials business and has a non- exclusive licence to manufacture and market CFQD® quantum dots Upfront Milestone Quarterly Fee for fee payment royalty services 2013 2014 payment

  14. Slide 14: Dow's CFQD Facility in Cheonan, South Korea

    DISPLAY 13 DOW’S CFQD FACILITY IN CHEONAN, SOUTH KOREA • The new Dow CFQD® quantum dot facility will enable mass production of cadmium-free quantum dots under Dow’s TREVISTATM brand • Facility is operational and has the capacity to support millions of large screen TVs • Sample requests have increase

  15. Slide 15: Components of the Wah Hong Agreement

    DISPLAY 14 COMPONENTS OF THE WAH HONG AGREEMENT • Wah Hong, headquartered in Taiwan, is a leading optical film manufacturer and supplier to the Taiwanese and Chinese display industry Upfront Two Sale of Quarterly payment milestone QD royalty 2017 - payments products payment 2023

  16. Slide 16: Wah Hong Progress to Date

    DISPLAY 15 WAH HONG PROGRESS TO DATE • Wah Hong is manufacturing film under Nanoco’s CFQD® Fine Color film brand from CFQD® purchased from Nanoco’s own production facility in Runcorn, UK • Commercial discussions are ongoing with various Asian display OEMs for use of the CFQD® Fine Color film • Hisen

  17. Slide 17: Components of the Merck Agreement

    DISPLAY 16 COMPONENTS OF THE MERCK AGREEMENT • Merck is headquartered in Germany and has c. 60% share of the liquid crystal polymer market • Non-exclusive licence to manufacture, market and sell CFQD® • Technology transfer progressing well and Merck is already producing small scale volumes of CFQD®s

  18. Slide 18: Go to Market Strategy

    DISPLAY 17 GO TO MARKET STRATEGY

  19. Slide 19: Runcorn Production Facility

    DISPLAY 18 RUNCORN PRODUCTION FACILITY • Nanoco’s existing production facility in Runcorn has been enhanced to meet expected demand from Wah Hong and Merck • ISO 9001:2015 certification for production and supply processes awarded in December 2016 • Scaling will require little additional capital expe

  20. Slide 20: Other Markets: General Lighting

    OTHER MARKETS 19 GENERAL LIGHTING • Nanoco’s cadmium-free quantum dots have the ability to tune the colour of light emitted by LEDs such that any particular shade of light can be produced by tailoring the wavelengths • Potential applications for our technology are broad from improved white LED light

  21. Slide 21: Other Markets: Life Sciences

    OTHER MARKETS 20 LIFE SCIENCES • Life Science Division established to address the substantial opportunity for our CFQD® quantum dot technology in the healthcare sector • The team is lead by Dr Imad Nassani, who is one of the pioneers of the use of quantum dots in life sciences • Focus on in-vivo can

  22. Slide 22: Other Markets: Solar

    OTHER MARKETS 21 SOLAR • Our solar ink has been designed to maximise the absorption of energy and can be printed by low cost methods and annealed into a PV film • The technology is based on copper, indium, gallium, selenium (“CIGS”) materials • Current performance is 17% • We continue to work with L

  23. Slide 23: Summary

    SUMMARY 22 • Transformational year with the decision to adopt a non-exclusive licensing strategy in display, enabling us to increase the pace of commercialisation of our technology • New relationships established with Merck and Wah Hong have opened multiple sales channels into the display market • S

  24. Slide 24: Appendices

    APPENDICES

  25. Slide 25: Leadership

    APPENDICES 24 LEADERSHIP Dr Christopher Richards • CEO, Non-Executive chairman, Arysta LifeSciences Non Executive Chairman • 20 years of increasing management roles at Syngenta • Executive chairman of Plant Health Care • Non-executive director of Dechra Pharmaceuticals plc and of Origin Enterprises

  26. Slide 26: Statement of Comprehensive Income

    APPENDICES 25 STATEMENT OF COMPREHENSIVE INCOME 2016 2015 £’000 £’000 Revenue 474 2,029 Cost of sales (177) (316) Gross profit 297 1,713 Other operating income 284 — Operating expenses Research and development expenses (5,995) (5,580) Administrative expenses (7,367) (7,130) Operating loss (12,781) (

  27. Slide 27: Statement of Financial Position

    APPENDICES 26 STATEMENT OF FINANCIAL POSITION

  28. Slide 28: Statement of Financial Position

    APPENDICES 27 STATEMENT OF FINANCIAL POSITION

  29. Slide 29: TV Market Share

    APPENDICES 28 TV MARKET SHARE • Total LCD TV Shipments in 2015 was 226m

  30. Slide 30: TV Film Stack

    APPENDICES TV FILM STACK ° 29 General TFT-LCD Structure

  31. Slide 31: RoHS Update

    APPENDICIES 30 RoHS UPDATE • The European Commission has been conducting a lengthy and on- going review of the future of cadmium-based quantum dots • In spite of Members of the European Parliament voting overwhelmingly in 2015 to ban cadmium-containing quantum dots, the Commission decided to mandate

  32. Slide 32: Nanoco Group PLC

    31 Nanoco Group PLC 46 Grafton Street, Manchester, M13 9NT, United Kingdom, Tel: +44 161 603 7900 | Fax: +44 161 603 7901 info@nanocotechnologies.com www.nanocogroup.com

Nanoco Group — 19th Annual Needham Growth Conference 2017 on 6ix